BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15031351)

  • 1. Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children.
    Fischbach M; Terzic J; Chauvé S; Laugel V; Muller A; Haraldsson B
    Nephrol Dial Transplant; 2004 Apr; 19(4):925-32. PubMed ID: 15031351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between intraperitoneal hydrostatic pressure and dialysate volume in children on PD.
    Fischbach M; Terzic J; Becmeur F; Lahlou A; Desprez P; Battouche D; Geisert J
    Adv Perit Dial; 1996; 12():330-4. PubMed ID: 8865930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.
    Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos DG
    Adv Perit Dial; 2001; 17():42-6. PubMed ID: 11510294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peritoneal membrane: a dynamic dialysis membrane in children.
    Fischbach M; Haraldsson B; Helms P; Danner S; Laugel V; Terzic J
    Adv Perit Dial; 2003; 19():265-8. PubMed ID: 14763076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of increased intraperitoneal fill volume on tolerance and dialysis effectiveness in children.
    Fischbach M; Terzic J; Gaugler C; Bergere V; Munch K; Hamel G; Provot E; Donnars F
    Adv Perit Dial; 1998; 14():258-64. PubMed ID: 10649737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal pressure in PD patients: relationship to intraperitoneal volume, body size and PD-related complications.
    Dejardin A; Robert A; Goffin E
    Nephrol Dial Transplant; 2007 May; 22(5):1437-44. PubMed ID: 17308323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fill volume changes on peritoneal dialysis tolerance and effectiveness in children.
    Fischbach M; Terzic J; Menouer S; Bergere V; Ferjani L; Haraldsson B
    Adv Perit Dial; 2000; 16():321-3. PubMed ID: 11045320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
    Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
    Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
    Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
    Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrostatic intraperitoneal pressure in children on peritoneal dialysis: practical implications. An 18-month clinical experience.
    Fischbach M; Desprez P; Donnars F; Geisert J
    Adv Perit Dial; 1994; 10():294-6. PubMed ID: 7999848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids.
    Yamamoto T; Tomo T; Okabe E; Namoto S; Suzuki K; Hirao Y
    Nephrol Dial Transplant; 2009 May; 24(5):1436-42. PubMed ID: 19033251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.